Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded ATP synthase membrane subunit 8 (MT-ATP8) is a small subunit of the F₀ portion of ATP synthase (Complex V) in the inner mitochondrial membrane. This essential enzyme complex generates ATP, the main cellular energy molecule, by coupling ADP phosphorylation to proton flow produced by the mitochondrial electron transport chain. MT-ATP8 is encoded by mitochondrial DNA and is not itself catalytically active, but is believed to stabilize and structurally organize the F₀ membrane domain, anchoring the stator to prevent futile rotation as protons translocate. Mutations in MT-ATP8 are implicated in diverse mitochondrial disorders, including hypertrophic cardiomyopathy, Leigh syndrome, and other multi-system diseases. There are no approved drugs specifically targeting this subunit, and inhibition of ATP synthase by agents such as oligomycin can have severe cytotoxic consequences due to abrogated energy production.
None established as there are no drugs specifically targeting this subunit. Drugs such as oligomycin inhibit the F₀ complex as a whole, blocking proton flow and ATP synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded ATP synthase membrane subunit 8 (MT-ATP8).